Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: The Zoledronic Acid/Androgen Blockade Trial on Prostate Cancer (Zabton-PC) study

被引：1
|
作者：
Ueno, Satoru
Mizokami, Atsushi
Fukagai, Takashi
Fujimoto, Naohiro
Ohoka, Hitoshi
Kondo, Yukihiro
Arai, Gaku
Ide, Hisamitsu
Namiki, Mikio
机构：
[1] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan
[2] Showa Univ, Sch Med, Tokyo 142, Japan
[3] Univ Occupat & Environm Hlth, Kitakyushu, Japan
[4] Kobe Med Ctr, Natl Hosp Org, Kobe, Hyogo, Japan
[5] Nippon Med Sch, Dept Urol, Tokyo 113, Japan
[6] Dokkyo Med Univ, Koshigaya Hosp, Saitama, Japan
[7] Teikyo Univ Hosp, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.207
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
207
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy of Combined Androgen Blockade with Zoledronic Acid Treatment in Prostate Cancer with Bone Metastasis: The ZABTON-PC (Zoledronic Acid/Androgen Blockade Trial on Prostate Cancer) Study
    Ueno, Satoru
    Mizokami, Atsushi
    Fukagai, Takashi
    Fujimoto, Naohiro
    Oh-Oka, Hitoshi
    Kondo, Yukihiro
    Arai, Gaku
    Ide, Hisamitsu
    Horie, Shigeo
    Ueki, Osamu
    Kawaguchi, Kouhei
    Shimamura, Masayoshi
    Orito, Matsuo
    Ishida, Takeyuki
    Ikeda, Daisuke
    Namiki, Mikio
    ANTICANCER RESEARCH, 2013, 33 (09) : 3837 - 3844
  • [2] Randomized study on the effect of zoledronic acid treatment for prostate cancer with bone metastasis during initial combined androgen blockade
    Ueno, Satoru
    Mizokami, Atsushi
    Namiki, Mikio
    Fukagai, Takashi
    Fujimoto, Naohiro
    Ooka, Hitoshi
    Kondo, Yukihiro
    Arai, Gaku
    Ide, Hisamitsu
    Kataoka, Kazuyoshi
    Kawaguchi, Kohei
    Shimamura, Masayoshi
    Orito, Matsuo
    Ishida, Takeyuki
    Ikeda, Daisuke
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [3] Effect of zoledronic acid on bone loss associated with androgen blockade for prostate cancer
    Casey, R
    Love, W
    Pearson, D
    Reymond, D
    Zarenda, M
    BONE, 2004, 34 : S84 - S84
  • [4] Long term zoledronic acid during androgen blockade for prostate cancer
    Casey, Richard
    Gesztesi, Zsuzsanna
    Rochford, Joseph
    CANADIAN JOURNAL OF UROLOGY, 2010, 17 (03) : 5170 - 5177
  • [5] Zoledronic acid prevents decreases in bone mineral density in patients with prostate cancer undergoing combined androgen blockade
    Nishizawa, Satoshi
    Inagaki, Takeshi
    Iba, Akinori
    Kikkawa, Kazuro
    Kodama, Yoshiki
    Matsumura, Nagahide
    Kohjimoto, Yasuo
    Hara, Isao
    SPRINGERPLUS, 2014, 3
  • [6] Additive effect of zoledronic acid on serum prostate-specific antigen changes for hormone-sensitive prostate cancer patients with bone metastasis treated by combined androgen blockade
    Kamiya, Naoto
    Suzuki, Hiroyoshi
    Endo, Takumi
    Takano, Makoto
    Yano, Masashi
    Naoi, Makito
    Nishimi, Daisuke
    Kawamura, Koji
    Imamoto, Takashi
    Ichikawa, Tomohiko
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (02) : 169 - 173
  • [7] Phase II trial of zoledronic acid combined with androgen-deprivation therapy for treatment-na⟨ve prostate cancer with bone metastasis
    Nozawa, Masahiro
    Inagaki, Takeshi
    Nagao, Kazuhiro
    Nishioka, Tsukasa
    Komura, Takahiro
    Esa, Atsunobu
    Kitagawa, Michio
    Imanishi, Masaaki
    Uekado, Yasunari
    Ogawa, Takatoshi
    Kajikawa, Hiroshi
    Uejima, Shigeya
    Matsuyama, Hideyasu
    Hara, Isao
    Uemura, Hirotsugu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) : 693 - 701
  • [8] Phase II trial of zoledronic acid combined with androgen-deprivation therapy for treatment-naïve prostate cancer with bone metastasis
    Masahiro Nozawa
    Takeshi Inagaki
    Kazuhiro Nagao
    Tsukasa Nishioka
    Takahiro Komura
    Atsunobu Esa
    Michio Kitagawa
    Masaaki Imanishi
    Yasunari Uekado
    Takatoshi Ogawa
    Hiroshi Kajikawa
    Shigeya Uejima
    Hideyasu Matsuyama
    Isao Hara
    Hirotsugu Uemura
    International Journal of Clinical Oncology, 2014, 19 : 693 - 701
  • [9] Combined androgen blockade for the treatment of metastatic cancer of the prostate
    Schellhammer, PF
    UROLOGY, 1996, 47 (05) : 622 - 628
  • [10] A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial
    Tomomi Kamba
    Toshiyuki Kamoto
    Shinichiro Maruo
    Takashi Kikuchi
    Yosuke Shimizu
    Shunichi Namiki
    Kiyohide Fujimoto
    Hiroaki Kawanishi
    Fuminori Sato
    Shintaro Narita
    Takefumi Satoh
    Hideo Saito
    Mikio Sugimoto
    Jun Teishima
    Naoya Masumori
    Shin Egawa
    Hideki Sakai
    Yusaku Okada
    Toshiro Terachi
    Osamu Ogawa
    International Journal of Clinical Oncology, 2017, 22 : 166 - 173
12345